Cetera Investment Advisers
WST icon

Cetera Investment Advisers’s West Pharmaceutical WST Stock Holding History

Cetera Investment Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.61M Sell
23,974
-84
-0.3% -$25.7K 0.01% 1247
2026
Q1 		$6.03M Sell
24,058
-6,077
-20% -$1.51M 0.01% 1380
2025
Q4 		$8.29M Sell
30,135
-679
-2% -$186K 0.01% 1143
2025
Q3 		$8.08M Buy
30,814
+6,423
+26% +$1.56M 0.01% 1120
2025
Q2 		$5.34M Buy
24,391
+941
+4% +$201K 0.01% 1150
2025
Q1 		$5.25M Buy
23,450
+2,879
+14% +$793K 0.01% 1082
2024
Q4 		$6.74M Buy
20,571
+1,239
+6% +$390K 0.01% 888
2024
Q3 		$5.8M Sell
19,332
-49
-0.3% -$15K 0.01% 935
2024
Q2 		$6.38M Buy
19,381
+391
+2% +$138K 0.01% 870
2024
Q1 		$7.51M Buy
18,990
+15,952
+525% +$5.9M 0.02% 783
2023
Q4 		$1.07M Buy
3,038
+78
+3% +$27.6K 0.01% 1072
2023
Q3 		$1.11M Sell
2,960
-366
-11% -$142K 0.01% 1000
2023
Q2 		$1.27M Buy
3,326
+79
+2% +$28.2K 0.01% 962
2023
Q1 		$1.13M Sell
3,247
-114
-3% -$33.3K 0.01% 977
2022
Q4 		$791K Buy
3,361
+396
+13% +$93.8K 0.01% 1105
2022
Q3 		$730K Sell
2,965
-185
-6% -$56.4K 0.01% 840
2022
Q2 		$952K Sell
3,150
-1,714
-35% -$558K 0.02% 819
2022
Q1 		$2M Buy
4,864
+207
+4% +$81K 0.03% 562
2021
Q4 		$2.18M Sell
4,657
-956
-17% -$412K 0.03% 523
2021
Q3 		$2.38M Buy
5,613
+996
+22% +$420K 0.04% 463
2021
Q2 		$1.66M Buy
4,617
+2,332
+102% +$770K 0.03% 580
2021
Q1 		$644K Sell
2,285
-1,439
-39% -$412K 0.01% 848
2020
Q4 		$1.05M Buy
+3,724
New +$1.05M 0.02% 641

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cetera Investment Advisers's WST Position: Q2 2026 in Review

Cetera Investment Advisers reduced its West Pharmaceutical (WST) stake by 0.35% in Q2 2026, selling an estimated $25.7K and leaving 23,974 shares worth $8.61M. The position accounts for 0.01% of the portfolio, ranked #1247.

Cetera Investment Advisers first reported a position in WST in Q4 2020 and has held it in 23 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cetera Investment Advisers held 23,974 shares of West Pharmaceutical worth $8.61M as of Q2 2026.
  • Cetera Investment Advisers sold 84 West Pharmaceutical shares in Q2 2026, an estimated $25.7K.
  • West Pharmaceutical made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1247 holding.
  • Cetera Investment Advisers first reported a position in West Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.